Close Menu

NEW YORK – Twist Bioscience and enzyme engineering firm Watchmaker Genomics announced Tuesday a partnership on high-throughput applications of next-generation sequencing, including tumor profiling, inherited disease diagnostics, liquid biopsies, and minimal residual disease (MRD) monitoring.

Under the terms of the deal, the partners will create products, the first of which will incorporate Watchmaker's high-fidelity library amplification master mix into Twist's enzymatic library preparation kit.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

NPR reports that researchers have developed chimeric embryos as part of work toward growing human organs in animals for organ transplants.

According to the Washington Post, the Biden Administration is set to make changes to federal restrictions on fetal tissue research.

In Science this week: approach to isolated trace DNA from archaic humans from sediments, and more.

Texas Monthly looks into the DNA Zoo being collected by Baylor College of Medicine researchers.